Global Gene Therapy Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Gene Therapy Drugs
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Gene Therapy Drugs by Type
  • 1.3.1 Overview: Global Gene Therapy Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Gene Therapy Drugs Consumption Value Market Share by Type in 2022
  • 1.3.3 Neuromuscular Disease
  • 1.3.4 Genetic Disease
  • 1.3.5 Other
• 1.4 Global Gene Therapy Drugs Market by Application
  • 1.4.1 Overview: Global Gene Therapy Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Hospital
  • 1.4.3 Pharmacy
• 1.5 Global Gene Therapy Drugs Market Size & Forecast
• 1.6 Global Gene Therapy Drugs Market Size and Forecast by Region
  • 1.6.1 Global Gene Therapy Drugs Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Gene Therapy Drugs Market Size by Region, (2018-2029)
  • 1.6.3 North America Gene Therapy Drugs Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Gene Therapy Drugs Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Gene Therapy Drugs Market Size and Prospect (2018-2029)
  • 1.6.6 South America Gene Therapy Drugs Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Gene Therapy Drugs Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 F. Hoffmann-La Roche AG
  • 2.1.1 F. Hoffmann-La Roche AG Details
  • 2.1.2 F. Hoffmann-La Roche AG Major Business
  • 2.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Product and Solutions
  • 2.1.4 F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 F. Hoffmann-La Roche AG Recent Developments and Future Plans
• 2.2 Novartis International AG
  • 2.2.1 Novartis International AG Details
  • 2.2.2 Novartis International AG Major Business
  • 2.2.3 Novartis International AG Gene Therapy Drugs Product and Solutions
  • 2.2.4 Novartis International AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 Novartis International AG Recent Developments and Future Plans
• 2.3 Gilead Sciences, Inc.
  • 2.3.1 Gilead Sciences, Inc. Details
  • 2.3.2 Gilead Sciences, Inc. Major Business
  • 2.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Product and Solutions
  • 2.3.4 Gilead Sciences, Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Gilead Sciences, Inc. Recent Developments and Future Plans
• 2.4 Ultragenyx Pharmaceutical，Inc.
  • 2.4.1 Ultragenyx Pharmaceutical，Inc. Details
  • 2.4.2 Ultragenyx Pharmaceutical，Inc. Major Business
  • 2.4.3 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Product and Solutions
  • 2.4.4 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 Ultragenyx Pharmaceutical，Inc. Recent Developments and Future Plans
• 2.5 Applied Genetic Technologies Corp
  • 2.5.1 Applied Genetic Technologies Corp Details
  • 2.5.2 Applied Genetic Technologies Corp Major Business
  • 2.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Product and Solutions
  • 2.5.4 Applied Genetic Technologies Corp Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 Applied Genetic Technologies Corp Recent Developments and Future Plans
• 2.6 Audentes Therapeutics
  • 2.6.1 Audentes Therapeutics Details
  • 2.6.2 Audentes Therapeutics Major Business
  • 2.6.3 Audentes Therapeutics Gene Therapy Drugs Product and Solutions
  • 2.6.4 Audentes Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 Audentes Therapeutics Recent Developments and Future Plans
• 2.7 BioMarin Pharmaceutical
  • 2.7.1 BioMarin Pharmaceutical Details
  • 2.7.2 BioMarin Pharmaceutical Major Business
  • 2.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Product and Solutions
  • 2.7.4 BioMarin Pharmaceutical Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 BioMarin Pharmaceutical Recent Developments and Future Plans
• 2.8 Bluebird Bio
  • 2.8.1 Bluebird Bio Details
  • 2.8.2 Bluebird Bio Major Business
  • 2.8.3 Bluebird Bio Gene Therapy Drugs Product and Solutions
  • 2.8.4 Bluebird Bio Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Bluebird Bio Recent Developments and Future Plans
• 2.9 Nightstar Therapeutics
  • 2.9.1 Nightstar Therapeutics Details
  • 2.9.2 Nightstar Therapeutics Major Business
  • 2.9.3 Nightstar Therapeutics Gene Therapy Drugs Product and Solutions
  • 2.9.4 Nightstar Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 Nightstar Therapeutics Recent Developments and Future Plans
• 2.10 Sangamo Therapeutics
  • 2.10.1 Sangamo Therapeutics Details
  • 2.10.2 Sangamo Therapeutics Major Business
  • 2.10.3 Sangamo Therapeutics Gene Therapy Drugs Product and Solutions
  • 2.10.4 Sangamo Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Sangamo Therapeutics Recent Developments and Future Plans
• 2.11 Spark Therapeutics
  • 2.11.1 Spark Therapeutics Details
  • 2.11.2 Spark Therapeutics Major Business
  • 2.11.3 Spark Therapeutics Gene Therapy Drugs Product and Solutions
  • 2.11.4 Spark Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.11.5 Spark Therapeutics Recent Developments and Future Plans
• 2.12 uniQure
  • 2.12.1 uniQure Details
  • 2.12.2 uniQure Major Business
  • 2.12.3 uniQure Gene Therapy Drugs Product and Solutions
  • 2.12.4 uniQure Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.12.5 uniQure Recent Developments and Future Plans
• 2.13 VBL Therapeutics
  • 2.13.1 VBL Therapeutics Details
  • 2.13.2 VBL Therapeutics Major Business
  • 2.13.3 VBL Therapeutics Gene Therapy Drugs Product and Solutions
  • 2.13.4 VBL Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.13.5 VBL Therapeutics Recent Developments and Future Plans
• 2.14 Voyager Therapeutics
  • 2.14.1 Voyager Therapeutics Details
  • 2.14.2 Voyager Therapeutics Major Business
  • 2.14.3 Voyager Therapeutics Gene Therapy Drugs Product and Solutions
  • 2.14.4 Voyager Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
  • 2.14.5 Voyager Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Gene Therapy Drugs Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Gene Therapy Drugs by Company Revenue
  • 3.2.2 Top 3 Gene Therapy Drugs Players Market Share in 2022
  • 3.2.3 Top 6 Gene Therapy Drugs Players Market Share in 2022
• 3.3 Gene Therapy Drugs Market: Overall Company Footprint Analysis
  • 3.3.1 Gene Therapy Drugs Market: Region Footprint
  • 3.3.2 Gene Therapy Drugs Market: Company Product Type Footprint
  • 3.3.3 Gene Therapy Drugs Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Gene Therapy Drugs Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global Gene Therapy Drugs Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Gene Therapy Drugs Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Gene Therapy Drugs Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Gene Therapy Drugs Consumption Value by Type (2018-2029)
• 6.2 North America Gene Therapy Drugs Consumption Value by Application (2018-2029)
• 6.3 North America Gene Therapy Drugs Market Size by Country
  • 6.3.1 North America Gene Therapy Drugs Consumption Value by Country (2018-2029)
  • 6.3.2 United States Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Gene Therapy Drugs Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Gene Therapy Drugs Consumption Value by Type (2018-2029)
• 7.2 Europe Gene Therapy Drugs Consumption Value by Application (2018-2029)
• 7.3 Europe Gene Therapy Drugs Market Size by Country
  • 7.3.1 Europe Gene Therapy Drugs Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 7.3.3 France Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Gene Therapy Drugs Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Gene Therapy Drugs Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific Gene Therapy Drugs Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Gene Therapy Drugs Market Size by Region
  • 8.3.1 Asia-Pacific Gene Therapy Drugs Consumption Value by Region (2018-2029)
  • 8.3.2 China Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 8.3.5 India Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Gene Therapy Drugs Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Gene Therapy Drugs Consumption Value by Type (2018-2029)
• 9.2 South America Gene Therapy Drugs Consumption Value by Application (2018-2029)
• 9.3 South America Gene Therapy Drugs Market Size by Country
  • 9.3.1 South America Gene Therapy Drugs Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Gene Therapy Drugs Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Gene Therapy Drugs Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa Gene Therapy Drugs Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Gene Therapy Drugs Market Size by Country
  • 10.3.1 Middle East & Africa Gene Therapy Drugs Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Gene Therapy Drugs Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Gene Therapy Drugs Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Gene Therapy Drugs Market Drivers
• 11.2 Gene Therapy Drugs Market Restraints
• 11.3 Gene Therapy Drugs Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Gene Therapy Drugs Industry Chain
• 12.2 Gene Therapy Drugs Upstream Analysis
• 12.3 Gene Therapy Drugs Midstream Analysis
• 12.4 Gene Therapy Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source